Table 5.
Parameters | CTRL | CMO | CMO + ZO | CMO + Clp | |
---|---|---|---|---|---|
Serum | Creatinine (µmol/L) | 30.5 ± 0.86 | 36.33 ± 1.08** | 29.83 ± 1.19## | 30.16 ± 1.37## |
Urea (mmol/L) | 6.15 ± 0.06 | 7.63 ± 0.29** | 6.26 ± 0.15## | 6.73 ± 0.14# | |
Uric acid (mmol/L) | 67.5 ± 1.32 | 77.83 ± 2.75* | 68.5 ± 1.17# | 68.8 ± 1.30# | |
Urine | Creatinine (µmol/L) | 9.54 ± 0.56 | 7.25 ± 0.47* | 9.21 ± 0.20## | 8.91 ± 0.40# |
Urea (mmol/L) | 1359 ± 146.24 | 978 ± 28.40* | 1324 ± 108.58# | 1322 ± 120.09# | |
Uric acid (mmol/L) | 618 ± 42.47 | 889 ± 86.96* | 641.75 ± 46.08# | 612 ± 110.70 |
The data represent the mean ± SEM. Comparisons are made between two groups: Osteoporotic (CMO) versus control group (CTRL): *p < 0.05; **p < 0.01. Osteoporotic treated with ZO (CMO + ZO) or Clp (CMO + Clp) versus osteoporotic group (CMO): #p < 0.05; ##p < 0.01. ZO Zingiber officinale, Clp Calperos